Sera Prognostics, Inc. (SERA)Healthcare | Medical Devices | Salt Lake City, United States | NasdaqGM
2.30 USD
-0.05
(-2.128%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 2.30 Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:26 p.m. EDT
SERA is a highly volatile stock with a negative earnings outlook and low liquidity, making it a risky proposition for both short-term and long-term investors. The recent news highlights mixed signals, with some positive analyst upgrades but also concerns about growth and product adoption. The lack of dividends and negative fundamentals further reduce its appeal. While the options activity suggests some interest, it is not enough to justify investment without a clear catalyst. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.291776 |
| AutoARIMA | 0.298742 |
| AutoETS | 0.299859 |
| MSTL | 0.304677 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 48% |
| H-stat | 5.19 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.241 |
| Excess Kurtosis | -1.02 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.102 |
| Revenue per Share | 0.002 |
| Market Cap | 90,030,848 |
| Forward P/E | -3.36 |
| Beta | 1.06 |
| Website | https://www.sera.com |
As of April 11, 2026, 4:26 p.m. EDT: Options speculators are showing a mixed sentiment. For near-term expirations (April 17 and May 15), there is limited activity with calls and puts, but the IV is relatively high, suggesting some uncertainty or anticipation. For the longer-term expiration (January 15, 2027), there is more activity with puts, indicating potential bearish sentiment, especially around the 7.5 strike. The presence of puts with higher IV at the 5.0 and 10.0 strikes suggests some speculation about a potential price increase, but the overall activity is low, indicating limited confidence in either direction.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.3067847 |
| Address1 | 2,749 East Parleys Way |
| Address2 | Suite 200 |
| All Time High | 15.5 |
| All Time Low | 1.1 |
| Ask | 2.98 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 33,190 |
| Average Daily Volume3 Month | 57,811 |
| Average Volume | 57,811 |
| Average Volume10Days | 33,190 |
| Beta | 1.057 |
| Bid | 1.67 |
| Bid Size | 2 |
| Book Value | 1.936 |
| City | Salt Lake City |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.3 |
| Current Ratio | 1.686 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.35 |
| Day Low | 2.3 |
| Debt To Equity | 3.102 |
| Display Name | Sera Prognostics |
| Earnings Call Timestamp End | 1,773,867,600 |
| Earnings Call Timestamp Start | 1,773,867,600 |
| Earnings Timestamp | 1,773,864,000 |
| Earnings Timestamp End | 1,778,097,600 |
| Earnings Timestamp Start | 1,778,097,600 |
| Ebitda | -35,680,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.49 |
| Enterprise To Revenue | 656.406 |
| Enterprise Value | 53,168,852 |
| Eps Current Year | -0.68 |
| Eps Forward | -0.685 |
| Eps Trailing Twelve Months | -0.67 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 801 990 6601 |
| Fifty Day Average | 2.1889 |
| Fifty Day Average Change | 0.11109996 |
| Fifty Day Average Change Percent | 0.050756067 |
| Fifty Two Week Change Percent | -30.678469 |
| Fifty Two Week High | 4.09 |
| Fifty Two Week High Change | -1.7900002 |
| Fifty Two Week High Change Percent | -0.43765286 |
| Fifty Two Week Low | 1.37 |
| Fifty Two Week Low Change | 0.92999995 |
| Fifty Two Week Low Change Percent | 0.67883205 |
| Fifty Two Week Range | 1.37 - 4.09 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,626,355,800,000 |
| Float Shares | 27,410,480 |
| Forward Eps | -0.685 |
| Forward P E | -3.357664 |
| Free Cashflow | -17,447,624 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 71 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -1.02469 |
| Gross Profits | -83,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.10987 |
| Held Percent Institutions | 0.5787 |
| Implied Shares Outstanding | 39,143,848 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-07-15 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. |
| Long Name | Sera Prognostics, Inc. |
| Market | us_market |
| Market Cap | 90,030,848 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_117852744 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -31,928,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 91,596,604 |
| Number Of Analyst Opinions | 1 |
| Open | 2.347 |
| Operating Cashflow | -25,623,000 |
| Operating Margins | -895.4 |
| Payout Ratio | 0.0 |
| Phone | 801 990 0520 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 2.3 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 2.35 |
| Price Eps Current Year | -3.3823528 |
| Price Hint | 4 |
| Price To Book | 1.1880165 |
| Price To Sales Trailing12 Months | 1,111.492 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.621 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.05 |
| Regular Market Change Percent | -2.12766 |
| Regular Market Day High | 2.35 |
| Regular Market Day Low | 2.3 |
| Regular Market Day Range | 2.3 - 2.35 |
| Regular Market Open | 2.347 |
| Regular Market Previous Close | 2.35 |
| Regular Market Price | 2.3 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 47,595 |
| Return On Assets | -0.26148 |
| Return On Equity | -0.51827 |
| Revenue Growth | -0.583 |
| Revenue Per Share | 0.002 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 38,176,089 |
| Shares Percent Shares Out | 0.0097 |
| Shares Short | 381,493 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 283,783 |
| Short Name | Sera Prognostics, Inc. |
| Short Percent Of Float | 0.0123000005 |
| Short Ratio | 3.87 |
| Source Interval | 15 |
| State | UT |
| Symbol | SERA |
| Target High Price | 5.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 5.0 |
| Target Median Price | 5.0 |
| Total Cash | 39,201,000 |
| Total Cash Per Share | 1.001 |
| Total Debt | 2,339,000 |
| Total Revenue | 81,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.67 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.84735 |
| Two Hundred Day Average Change | -0.54734993 |
| Two Hundred Day Average Change Percent | -0.19223136 |
| Type Disp | Equity |
| Volume | 47,595 |
| Website | https://www.sera.com |
| Zip | 84,109 |